highlights in research

---

 FDA approves 10 cities across the USA to administer MDMA in a Phase 3 clinical trial. 

 Imperial College of London Centre for Psychedelic Research is studying the effects of Psilocybin and treating Fibromyalgia. 

 A theory is that low doses of psychedelics induce their effects via alterations in the gut microbiome and related pathways to the brain. 

 Lifetime use of naturalistic psychedelics was associated with a 60% reduced hazard for suicidality. 

 Psychedelic use resulted in a 14% reduced likelihood of suicidal thinking within the past year, a 29% reduced likelihood of suicide planning within the past year, and a 36% reduced likelihood of attempting suicide within the past year. 

 97 clinical trials recruiting volunteer participants.